Consensus Chongqing Zhifei Biological Products Co., Ltd.
Equities
300122
CNE100000V20
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
25.40 CNY | +3.04% |
|
+5.44% | -3.42% |
Dec. 09 | Chongqing Zhifei Biological, GSK Adjust Terms of Cooperation Agreement | MT |
Dec. 05 | GSK, China's Zhifei Extend Shingles Shot Collaboration to 2034 | DJ |
Evolution of the Average Target: Chongqing Zhifei Biological Products Co., Ltd.
Evolution of the Target Price: Chongqing Zhifei Biological Products Co., Ltd.
Changes in Analyst Recommendations: Chongqing Zhifei Biological Products Co., Ltd.
Consensus | 4m Revision of opinion | Divergence of analysts' opinions | Divergence of Target Price | Ecart obj. / dr | ||
---|---|---|---|---|---|---|
+46.61% | ||||||
+19.78% | ||||||
+14.24% | ||||||
+5.8% | ||||||
+58.29% | ||||||
+44.13% | ||||||
+6.41% | ||||||
+4.41% | ||||||
+50.54% | ||||||
-9.72% | ||||||
Average | +24.05% | |||||
Weighted average by Cap. | +20.48% |
Analysts' Consensus

Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
UBS |
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 300122 Stock
- Consensus Chongqing Zhifei Biological Products Co., Ltd.